166 related articles for article (PubMed ID: 25292036)
1. Preparation of 5-fluorouracil-loaded nanoparticles and study of interaction with gastric cancer cells.
Fan YL; Fan BY; Li Q; Di HX; Meng XY; Ling N
Asian Pac J Cancer Prev; 2014; 15(18):7611-5. PubMed ID: 25292036
[TBL] [Abstract][Full Text] [Related]
2. Encapsulation and Systemic Delivery of 5-Fluorouracil Conjugated with Silkworm Pupa Derived Protein Nanoparticles for Experimental Lymphoma Cancer.
Reneeta NP; Thiyonila B; Aathmanathan VS; Ramya T; Chandrasekar P; Subramanian N; Prajapati VK; Krishnan M
Bioconjug Chem; 2018 Sep; 29(9):2994-3009. PubMed ID: 30089206
[TBL] [Abstract][Full Text] [Related]
3. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells.
Laquintana V; Denora N; Lopalco A; Lopedota A; Cutrignelli A; Lasorsa FM; Agostino G; Franco M
Mol Pharm; 2014 Mar; 11(3):859-71. PubMed ID: 24410438
[TBL] [Abstract][Full Text] [Related]
4. Galactosylated chitosan/5-fluorouracil nanoparticles inhibit mouse hepatic cancer growth and its side effects.
Cheng MR; Li Q; Wan T; He B; Han J; Chen HX; Yang FX; Wang W; Xu HZ; Ye T; Zha BB
World J Gastroenterol; 2012 Nov; 18(42):6076-87. PubMed ID: 23155336
[TBL] [Abstract][Full Text] [Related]
5. Preparation and in vitro evaluation of 5-flourouracil loaded magnetite-zeolite nanocomposite (5-FU-MZNC) for cancer drug delivery applications.
Sağir T; Huysal M; Durmus Z; Kurt BZ; Senel M; Isık S
Biomed Pharmacother; 2016 Feb; 77():182-90. PubMed ID: 26796283
[TBL] [Abstract][Full Text] [Related]
6. A novel design of HA-coated nanoparticles co-encapsulating plasmid METase and 5-Fu shows enhanced application in targeting gastric cancer stem cells.
Yang W; Zhang H; Xin L
Biol Chem; 2018 Feb; 399(3):293-303. PubMed ID: 29016350
[TBL] [Abstract][Full Text] [Related]
7. Preparation of chitosan-polyaspartic acid-5-fluorouracil nanoparticles and its anti-carcinoma effect on tumor growth in nude mice.
Zhang DY; Shen XZ; Wang JY; Dong L; Zheng YL; Wu LL
World J Gastroenterol; 2008 Jun; 14(22):3554-62. PubMed ID: 18567086
[TBL] [Abstract][Full Text] [Related]
8. [Study of the anti-tumor effect of anti-vascular endothelial growth factor McAb 5-fluorouracil loaded polylactic acid nanoparticles].
Huang KH; Liu JH; Wang LY; Zhu ZH; Chen QK; Min J; Chen RF
Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Sep; 10(5):482-5. PubMed ID: 17851795
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of Biotin-Modified Galactosylated Chitosan Nanoparticles and Their Characteristics in Vitro and in Vivo.
Cheng M; Ma D; Zhi K; Liu B; Zhu W
Cell Physiol Biochem; 2018; 50(2):569-584. PubMed ID: 30308481
[TBL] [Abstract][Full Text] [Related]
10. Peri-tumor administration of 5-fluorouracil sol-gel using a hollow microneedle for treatment of gastric cancer.
Jung YS; Koo DH; Yang JY; Lee HY; Park JH; Park JH
Drug Deliv; 2018 Nov; 25(1):872-879. PubMed ID: 29608119
[TBL] [Abstract][Full Text] [Related]
11. Hyaluronidase enzyme core-5-fluorouracil-loaded chitosan-PEG-gelatin polymer nanocomposites as targeted and controlled drug delivery vehicles.
Rajan M; Raj V; Al-Arfaj AA; Murugan AM
Int J Pharm; 2013 Sep; 453(2):514-22. PubMed ID: 23796828
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic characteristics and anticancer effects of 5-fluorouracil loaded nanoparticles.
Li S; Wang A; Jiang W; Guan Z
BMC Cancer; 2008 Apr; 8():103. PubMed ID: 18412945
[TBL] [Abstract][Full Text] [Related]
13. Preparation and characterization of 5-fluorouracil-loaded PLLA-PEG/PEG nanoparticles by a novel supercritical CO2 technique.
Zhang C; Li G; Wang Y; Cui F; Zhang J; Huang Q
Int J Pharm; 2012 Oct; 436(1-2):272-81. PubMed ID: 22721846
[TBL] [Abstract][Full Text] [Related]
14. [Preparation of 5-fluorouracil encapsulated in amphiphilic polysaccharide nano-micelles and its killing effect on hepatocarcinoma cell line HepG2].
Zhou JJ; Chen RF; Tang QB; Zhou QB; Lu HW; Wang J
Ai Zheng; 2006 Dec; 25(12):1459-63. PubMed ID: 17166367
[TBL] [Abstract][Full Text] [Related]
15. Co-delivery of hypoxia inducible factor-1α small interfering RNA and 5-fluorouracil to overcome drug resistance in gastric cancer SGC-7901 cells.
Chen Y; Sun L; Guo D; Wu Z; Chen W
J Gene Med; 2017 Dec; 19(12):. PubMed ID: 29106062
[TBL] [Abstract][Full Text] [Related]
16. Polymeric nanoparticles for oral delivery of 5-fluorouracil: Formulation optimization, cytotoxicity assay and pre-clinical pharmacokinetics study.
Mattos AC; Altmeyer C; Tominaga TT; Khalil NM; Mainardes RM
Eur J Pharm Sci; 2016 Mar; 84():83-91. PubMed ID: 26775869
[TBL] [Abstract][Full Text] [Related]
17. Overcoming multidrug resistance in 2D and 3D culture models by controlled drug chitosan-graft poly(caprolactone)-based nanoparticles.
Shi WB; Le VM; Gu CH; Zheng YH; Lang MD; Lu YH; Liu JW
J Pharm Sci; 2014 Apr; 103(4):1064-74. PubMed ID: 24523221
[TBL] [Abstract][Full Text] [Related]
18. New chitosan nanospheres for the delivery of 5-fluorouracil: preparation, characterization and in vitro studies.
Cavalli R; Leone F; Minelli R; Fantozzi R; Dianzani C
Curr Drug Deliv; 2014; 11(2):270-8. PubMed ID: 24499357
[TBL] [Abstract][Full Text] [Related]
19. 5-flourouracil loaded N,O-carboxymethyl chitosan nanoparticles as an anticancer nanomedicine for breast cancer.
Anitha A; Chennazhi KP; Nair SV; Jayakumar R
J Biomed Nanotechnol; 2012 Feb; 8(1):29-42. PubMed ID: 22515092
[TBL] [Abstract][Full Text] [Related]
20. Irinotecan and 5-fluorouracil-co-loaded, hyaluronic acid-modified layer-by-layer nanoparticles for targeted gastric carcinoma therapy.
Gao Z; Li Z; Yan J; Wang P
Drug Des Devel Ther; 2017; 11():2595-2604. PubMed ID: 28919710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
